ClinicalTrials.Veeva

Menu

Comparing Collared and Collarless Femoral Stems in Primary Total Hip Arthroplasty

MedStar Health logo

MedStar Health

Status

Enrolling

Conditions

Primary Total Hip Arthroplasty

Treatments

Other: Collared Femoral Stem
Other: Collarless Femoral Stem

Study type

Interventional

Funder types

Other

Identifiers

NCT07337642
STUDY00009612

Details and patient eligibility

About

This is a prospective randomized control trial comparing two collared and collarless femoral implants used in primary total hip arthroplasty. The specific aims of this trial are to:

SA1: Prospectively assess clinical outcomes in patients undergoing primary total hip arthroplasty with a collared versus collarless femoral stem of the same design.

SA2: Evaluate serial radiographs to quantify differences in subsidence between collared and collarless implant groups.

SA3: Report and compare incidence rates of intraoperative and postoperative periprosthetic fractures and aseptic loosening following primary total hip arthroplasty with use of either a collared or collarless stem.

Hypothesis: The addition of a collar to the same designed triple-taper primary hip stem will lead to a reduction in subsidence and incidence of perioperative and periprosthetic femur fractures.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults (≥ 18 years old) scheduled for primary, uncemented THA using a cementless femoral stem
  • Diagnosis of primary osteoarthritis or other non-inflammatory degenerative joint disease.
  • Ability and willingness to comply with study procedures and follow-up schedule.
  • Ability to provide written informed consent

Exclusion criteria

  • Patients not indicated for a cementless THA
  • Prior surgery on the ipsilateral hip (e.g., prior THA, internal fixation, osteotomy)
  • Use of cemented or hybrid femoral components.
  • Revision THA or conversion THA
  • Active or prior infection of the hip joint.
  • Severe osteoporosis (T-score ≤ -2.5) or known metabolic bone disease.
  • Inability to complete follow-up or anticipated relocation out of the area.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 2 patient groups

Collard stem
Active Comparator group
Treatment:
Other: Collared Femoral Stem
Collarless stem
Active Comparator group
Treatment:
Other: Collarless Femoral Stem

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Miles Hollimon, B.S.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems